Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M329Revenue (TTM) $M104Net Margin (%)37.9Altman Z-Score8.8
Enterprise Value $M264EPS (TTM) $0.8Operating Margin %39.6Piotroski F-Score7
P/E(ttm)8.5Beneish M-Score-2.4Pre-tax Margin (%)39.0Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %--Quick Ratio4.0Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %--Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow8.7y-y EBITDA Growth Rate %344ROA % (ttm)43.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)59.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M46.3ROIC % (ttm)175Gross Margin Increase y-yY

Gurus Latest Trades with ENZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZDodge & Cox 2014-12-31 Sold Out -0.0001%$4.1 - $5.27
($4.76)
$ 7.1149%Sold Out0
ENZDodge & Cox 2014-09-30 Buy $4.55 - $6.08
($5.34)
$ 7.1133%New holding15,570
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZ is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ENZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KASTEN BERNARD LDirector 2016-03-11Sell42,782$4.0177.31view
KASTEN BERNARD LDirector 2014-10-24Sell15,900$4.9344.22view
RABBANI ELAZARCEO and Secretary 2011-11-16Buy20,000$2.29210.48view
WEINER BARRY WPres, CFO, Princ AO and Treasr 2011-11-16Buy20,000$2.29210.48view
BALEZENTIS CARL WPres., Enzo Life Sciences 2010-12-15Sell12,724$5.1238.87view
Kent Stephen B HDirector 2010-10-22Sell8,000$4.365.35view
Kent Stephen B HDirector 2010-08-05Sell2,500$4.4759.06view
Kent Stephen B HDirector 2010-06-11Sell5,000$4.2965.73view
Kent Stephen B HDirector 2010-03-15Sell5,000$6.1515.61view
KRENITSKY KEVINPresident, Enzo Clinical Labs 2009-10-15Buy6,600$7.7-7.66view

Quarterly/Annual Reports about ENZ:

News about ENZ:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CFO Buys Highlight: BWEN, ENZ, PIP, HAFC, AACC Nov 21 2011 
Enzo Biochem Inc. Reports Operating Results (10-Q) Mar 14 2011 
Enzo Biochem Inc. Reports Operating Results (10-Q) Dec 10 2010 
Enzo Biochem Inc. Reports Operating Results (10-Q) Jun 09 2010 
Enzo Biochem Inc. Reports Operating Results (10-Q) Dec 10 2009 
Weekly Top Insider Buys: Bank of America Corp., Safeway Inc., Umpqua Holdings Corp., National Penn B Oct 24 2009 
Weekly Top Insider Buys: KB Home, National Penn Bancshares Inc., Moduslink Global Solutions Inc., En Oct 20 2009 
Enzo Biochem Inc. Reports Operating Results (10-Q) Sep 04 2009 
Enzo Biochem Inc. (ENZ) Files Quarterly Report for the Period Ended on 2008-10-31 Dec 15 2008 

More From Other Websites
Biogen (BIIB) Presents Positive Phase III Data on Spinraza Jan 16 2017
Lilly, Merck Expand Tie-Up to Study Lartruvo-Keytruda Combo Jan 12 2017
ENZO BIOCHEM INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jan 10 2017
ARIAD Pharma Stock Gains on Acquisition Deal with Takeda Jan 10 2017
Halozyme Therapeutics (HALO) in Focus: Stock Up 6.4% Jan 10 2017
ETFs with exposure to Enzo Biochem, Inc. : January 9, 2017 Jan 09 2017
ETFs with exposure to Enzo Biochem, Inc. : December 29, 2016 Dec 29 2016
New Strong Buy Stocks for December 29th Dec 29 2016
ETFs with exposure to Enzo Biochem, Inc. : December 19, 2016 Dec 19 2016
ENZO BIOCHEM INC Financials Dec 14 2016
Enzo Biochem, Inc. :ENZ-US: Earnings Analysis: Q1, 2017 By the Numbers : December 14, 2016 Dec 14 2016
Enzo Biochem, Inc. (ENZ): Are Hedge Funds Right About This Stock? Dec 09 2016
ENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Dec 08 2016
Enzo Biochem Reports Improved First Quarter Results Dec 08 2016
ETFs with exposure to Enzo Biochem, Inc. : December 8, 2016 Dec 08 2016
Q1 2017 Enzo Biochem Inc Earnings Release - After Market Close Dec 08 2016
5 Reasonable Breakout Stocks for Exceptional Returns Dec 08 2016
Is Daktronics, Inc. (DAKT) A Good Stock To Buy? Dec 04 2016
Enzo Biochem Schedules Teleconference to Discuss First Quarter 2017 Results Friday, December 9, 2016... Dec 01 2016
ETFs with exposure to Enzo Biochem, Inc. : November 23, 2016 Nov 23 2016
Trump meets with The Times Nov 22 2016
Sullivan's spectacular stats from Dow's historic run Nov 22 2016
ENZO Biochem Reports Strong 2016 Operating Results Oct 13 2016
ENZO Biochem Schedules Teleconference to Discuss Fourth Quarter 2016 and Full Year Results Friday,... Oct 06 2016
Enzo Biochem Announces New York State Health Department Approval of New Easily Adaptable, Cost... Sep 21 2016
Enzo Biochem Announces New York State Health Department Approval of New Easily Adaptable, Cost... Sep 21 2016
Enzo Biochem Added To Russell 2000, Russell 3000 and Russell Global Indexes Jul 08 2016
Enzo Biochem’s Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware... Jul 08 2016
Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2016 Results Wednesday, June 8, 2016... Jun 03 2016
ENZO Biochem Collects $7 Million From Court Approved Escrow Fund Closings Jan 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)